NATCO Pharma Dividend
Dividend criteriumcontroles 4/6
NATCO Pharma is een dividendbetalend bedrijf met een huidig rendement van 0.39% dat ruimschoots wordt gedekt door de winst.
Belangrijke informatie
0.4%
Dividendrendement
6%
Uitbetalingsratio
| Gemiddelde opbrengst industrie | 0.7% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | ₹5.500 |
| Winst per aandeel | ₹91.37 |
| Toekomstig dividendrendement | 0.3% |
Recente dividendupdates
Recent updates
We Ran A Stock Scan For Earnings Growth And NATCO Pharma (NSE:NATCOPHARM) Passed With Ease
Oct 13
NATCO Pharma Limited's (NSE:NATCOPHARM) Shares Bounce 26% But Its Business Still Trails The Market
Aug 13If EPS Growth Is Important To You, NATCO Pharma (NSE:NATCOPHARM) Presents An Opportunity
Jul 15NATCO Pharma (NSE:NATCOPHARM) Seems To Use Debt Rather Sparingly
Jun 30NATCO Pharma Limited's (NSE:NATCOPHARM) Earnings Are Not Doing Enough For Some Investors
Jun 14NATCO Pharma Limited (NSE:NATCOPHARM) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
May 30Calculating The Fair Value Of NATCO Pharma Limited (NSE:NATCOPHARM)
May 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Apr 03NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.25
Feb 21NATCO Pharma Limited Just Beat EPS By 223%: Here's What Analysts Think Will Happen Next
Feb 18NATCO Pharma Limited (NSE:NATCOPHARM) Surges 25% Yet Its Low P/E Is No Reason For Excitement
Feb 17Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jan 25An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 37% Undervalued
Jan 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Dec 13An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 42% Undervalued
Sep 30Here's Why We Think NATCO Pharma (NSE:NATCOPHARM) Might Deserve Your Attention Today
Sep 12NATCO Pharma (NSE:NATCOPHARM) Is Paying Out A Larger Dividend Than Last Year
Aug 12Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jul 16NATCO Pharma Limited (NSE:NATCOPHARM) Shares Could Be 44% Below Their Intrinsic Value Estimate
Apr 20Is NATCO Pharma Limited (NSE:NATCOPHARM) Trading At A 46% Discount?
Dec 20NATCO Pharma's (NSE:NATCOPHARM) Upcoming Dividend Will Be Larger Than Last Year's
Aug 12Does NATCO Pharma (NSE:NATCOPHARM) Have A Healthy Balance Sheet?
Jun 23Broker Revenue Forecasts For NATCO Pharma Limited (NSE:NATCOPHARM) Are Surging Higher
Jun 02Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: De dividendbetalingen van NATCOPHARM zijn de afgelopen 10 jaar volatiel geweest.
Groeiend dividend: De dividendbetalingen van NATCOPHARM zijn de afgelopen 10 jaar gestegen.
Dividendrendement versus markt
| NATCO Pharma Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (NATCOPHARM) | 0.4% |
| Markt onderkant 25% (IN) | 0.2% |
| Markt Top 25% (IN) | 1.1% |
| Gemiddelde industrie (Pharmaceuticals) | 0.7% |
| Analist prognose (NATCOPHARM) (tot 3 jaar) | 0.3% |
Opmerkelijk dividend: Het dividend van NATCOPHARM ( 0.39% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de Indian markt ( 0.24% ).
Hoog dividend: Het dividend NATCOPHARM ( 0.39% ) is laag vergeleken met de top 25% van dividendbetalers in de Indian markt ( 1.08% ).
Winstuitkering aan aandeelhouders
Verdiendekking: Met zijn lage payout ratio ( 6% ) worden de dividendbetalingen van NATCOPHARM grotendeels gedekt door de winst.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Met zijn lage cash payout ratio ( 11.6% ) worden de dividendbetalingen van NATCOPHARM volledig gedekt door kasstromen.